Locations
South San Francisco, CA, USA · Morrisville, NC, USA
industry
Biotechnology
Size
51 - 200 employees
Stage
Series C+
founded in
2014
Encoded Therapeutics is creating one-time, disease-modifying gene therapies for pediatric Central Nervous System (CNS) disorders with its cell-selective targeting and regulation platform. The Encoded approach offers potentially unprecedented gene specificity and cell selectivity to unlock novel opportunities by targeting a range of disease mechanisms. Encoded’s technology is compatible with any delivery system to control where and when therapeutic transgenes are expressed, thereby shaping the functionality of target cells and holding broader therapeutic potential beyond CNS disorders. For more information, please visit www.encoded.com, and follow us on LinkedIn, Twitter @encodedtx, and YouTube. Social media guidelines: https://encoded.com/social-media-community-guidelines/
Something looks off?